Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1- The CM Study
Clinical Trial Grant
Awarded By
University of North Carolina - Chapel Hill
Start Date
March 1, 2023
End Date
June 30, 2025
Awarded By
University of North Carolina - Chapel Hill
Start Date
March 1, 2023
End Date
June 30, 2025